Why the Official Theory about COVID-19 Is Not Tenable
DOI:
https://doi.org/10.56098/vdwyqd57Keywords:
cellular immunity, COVID-19 pandemic theory, epidemiology, falsifiability theory, IgG versus IgM, rt-PCR test, SARS-CoV-2 specific antibodiesAbstract
Notwithstanding the huge number of scientific papers published on COVID-19, there are still critically important aspects of the story that have not been sufficiently studied. The problems concern the definition, the diagnosis, and the tests used. They are all questionable. Even if they all were tacitly accepted as correct, the current mainstream theory remains untenable: it cannot explain what happened, i.e., the pandemic in the version presented, more or less, as a scientific consensus. The simple reason is that the virus named “SARS-CoV-2” — according to surveys conducted with the widely used test for its identification — was already widespread in pre-pandemic years all around the globe before its official “birth”, and no one even noticed it. I discovered ample proof of this fact.
References
Abbott. (2020). Abbott Real Time SARS-CoV-2. For use under an Emergency Use Authorization (EUA) Only. Instructions for Use. REF 09N77-095. April 2020. https://www.molecular.abbott/content/dam/add/molecular/products/infectious-disease/realtime-sars-cov-2-assay/Fact%20Sheet%20for%20Healthcare%20Providers%20Abbott%20RealTime%20SARS-CoV-2.pdf
Abbott. (2025) Sars-cov-2 immunoassays Advancing diagnostics of covid-19 https://www.corelaboratory.abbott/us/en/offerings/segments/infectious-disease/sars-cov-2 (Downloaded in May 27, 2025)
Andersen KG, Rambaut A, Lipkin WL, Holmes EC, Garry RF. (2020). The proximal origin of SARS-CoV-2. Nat Med 26(4):450-452. https://doi.org/10.1038/s41591-020-0820-9
Anonymous. (2020). FDA clamps down on covid 19 antibody tests. Awesomecapital https://web.archive.org/web/20221207011821/https://awesomecapital.wordpress.com/2020/05/07/fda-clamps-down-on-covid-19-antibody-tests/
Apolone G, Montomoli E, Manenti A, Boeri M, Federica F, Hyseni I, Livia Mazzini L, Martinuzzi D, Cantone L, Milanese G, Sestini S, Suatoni P, Marchianò A, Bollati V, Sozzi G & Pastorino U (2021) Unexpected detection of SARS-CoV-2 antibodies in the prepandemic period in Italy. Tumors. Oct; 107(5):446-451. https://doi.org/10.1177/0300891620974755
Bandirali M, Sconfienza LM, Serra R, Brembilla R, Albano D, Pregliasco F E, Messina C. Chest Radiograph Findings in Asymptomatic and Minimally Symptomatic Quarantined Patients in Codogno, Italy during COVID-19 Pandemic. Radiology. 2020; 295(3):E7. https://pubs.rsna.org/doi/epdf/10.1148/radiol.2020201102
Basavaraju SV, et al. (2021) Serologic Testing of US Blood Donations to Identify Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2)-Reactive Antibodies: December 2019-January 2020. Clinical Infectious Diseases. 72(12):E1004-E1009. https://doi.org/10.1093/cid/ciaa1785
Borger P, et al. (2020). Corman-Drosten Review Report Curated by an International Consortium of Scientists in Life Sciences (ICSLS). https://www.academia.edu/68591924/Corman_Drosten_Review_Report_Curated_by_an_International_Consortium_of_Scientists_in_Life_Sciences_Icsls; also https://doi.org/10.31219/osf.io/9mjy7
Braun, J., Loyal, L., Frentsch, M. et al. (2020). SARS-CoV-2-reactive T cells in healthy donors and patients with COVID-19. Nature 587, 270-274. https://doi.org/10.1038/s41586-020-2598-9
Carrat F, Figoni J, Henny J, Desenclos JC, Kab S, de Lamballerie X, Zins M.(2021) Evidence of early circulation of SARS-CoV-2 in France: findings from the population-based "CONSTANCES" cohort. European Journal of Epidemiology. 36(2):219-222. https://doi.org/10.1007/s10654-020-00716-2
Centers for Disease Control and Prevention. (1981). Kaposi's sarcoma and pneumocystis pneumonia among homosexual men--New York City and California. Morbidity and Mortality Weekly Report, 1981;30:305-8. https://www.cdc.gov/mmwr/preview/mmwrhtml/00001114.htm
Centers for Disease Control and Prevention. (2023) National Notifiable Diseases Surveillance System (NNDSS). Coronavirus Disease 2019 (COVID-19) 2023 Case Definition. https://ndc.services.cdc.gov/case-definitions/coronavirus-disease-2019-2023/
Chan A (2024) Why the Pandemic Probably Started in a Lab, in 5 Key Points, The New York Times. https://www.nytimes.com/interactive/2024/06/03/opinion/covid-lab-leak.html
Corman VM, Landt O, Kaiser M, Molenkamp R, Meijer A, Chu DKW et al. (2020). Detection of 2019 novel coronavirus (2019-nCoV) by real-time RT-PCR. Euro Surveillance 25(3):2000045. https://doi.org/10.2807/1560-7917.ES.2020.25.3.2000045
Daszak, P. (2014-2019). Understanding the Risk of Bat Coronavirus Emergence. https://grantome.com/grant/NIH/R01-AI110964-06
Fleming RM (2021). Is COVID-19 a Bioweapon? A Scientific and Forensic Investigation (1st edition). Skyhorse. https://www.barnesandnoble.com/w/is-covid-19-a-bioweapon-richard-m-fleming/1139680021
Fongaro G, Stoco PH, Souza DSM, Grisard EC, Magri ME, Rogovski P, Schörner MA, et al. (2021). The presence of SARS-CoV-2 RNA in human sewage in Santa Catarina, Brazil, November 2019. Science of the Total Environment. 778 146198. https://doi.org/10.1016/j.scitotenv.2021.146198
Franchi F, Tomsic J. (2023) Comments on Kämmerer, et al. regarding RT-PCR Testing. International Journal of Vaccine Theory, Practice, and Research 3(1), June10, 2023. https://doi.org/10.56098/ijvtpr.v3i1.81
Gallagher J (2020). Are Coronavirus tests flawed? BBC. February 13, 2020. https://www.bbc.com/news/health-51491763
GISAID (2025). hCOV-19 Data Sharing. https://gisaid.org/
Gostin LO, Gronvall GK (2023). The Origins of COVID-19 - Why It Matters (and Why It Doesn't). New England Journal of Medicine. Jun 22; 388(25):2305-2308 https://doi.org/10.1056/NEJMp2305081
Grifoni A, Weiskopf D, Ramirez SI, Mateus J, Dan JM, Moderbacher CR, et al. (2020). Targets of T cell responses to SARS-CoV-2 coronavirus in humans with COVID-19 disease and unexposed individuals. Cell 181, 1489-1501.e15. https://doi.org/10.1016/j.cell.2020.05.015
Gumanova NG, Gorshkov AU, Bogdanova NL, Korolev AI, Drapkina OM (2022). Detection of Anti-SARS-CoV-2-S1 RBD-specific antibodies prior to and during the pandemic in 2011-2021 and COVID-19 observational study in 2019-2021. Vaccines (Basel) 10(4):581. PMID: 35455330; PMCID: PMC9032149. https://doi.org/10.3390/vaccines10040581
Hockett J, Engler J. (2024). Yes, We Believe the Bergamo (Italy) All-Cause Death Curve is Fraudulent. Nov 24, 2024. https://www.woodhouse76.com/p/yes-we-believe-the-bergamo-italy
Ioannidis JPA (2005). Why most published research findings are false. PLoS Med, 2(8), e124. https://doi.org/10.1371/journal.pmed.0020124
Ioannidis JPA (2020). Coronavirus disease 2019: The harms of exaggerated information and non-evidence-based measures. European Journal of Clinical Investigation 50: E13222.1-5. https://doi.org/10.1111/eci.13222
Ioannidis JPA, Contopoulos-Ioannidis DG. (2023). Prepandemic cross-reactive humoral immunity to SARS-CoV-2 in Africa: Systematic review and meta-analysis. International Journal of Infectious Diseases 134:160-167. Epub 2023 Jun 15. https://doi.org/10.1016/j.ijid.2023.06.009
Islam R, Raju RS, Tasnim N, Shihab IH, Bhuiyan MA, Araf Y, Islam T. (2021). Choice of assemblers has a critical impact on de novo assembly of SARS-CoV-2 genome and characterizing variants. Briefings in Bioinformatics 22(5):bbab102. https://doi.org/10.1093/bib/bbab102
Kämmerer U, Pekova S, Klement KJ, Louwen R., Borger P, Steger K.. (2023). RT-PCR test targeting the conserved 5'-UTRof SARS-CoV-2 overcomes shortcomings of the first WHO-recommended RT-PCR test. International Journal of Vaccine Theory, Practice, and Research 3(1) 818. https://doi.org/10.56098/ijvtpr.v3i1.71
Lai A, Tambuzzi S, Bergna A, Battistini A, Della Ventura C, Galli M, Zoja R, Zehender G, Cattaneo C. (2022). Evidence of SARS-CoV-2 Antibodies and RNA on autopsy cases in the pre-pandemic period in Milan (Italy). Frontiers in Microbiology 2022 Jun 15;13:886317. https://doi.org/10.3389/fmicb.2022.886317
La Rosa G, Mancini P, Bonanno Ferraro G, Veneri C, Iaconelli M, Bonadonna L, Lucentini L, Suffredini E. (2021). SARS-CoV-2 has been circulating in northern Italy since December 2019: Evidence from environmental monitoring. The Science of Total Environment 750:141711. https://doi.org/10.1016/j.scitotenv.2020.141711
La Rosa G, Mancini P, Iaconelli M, Veneri C, Bonanno Ferraro G, Del Giudice C, Suffredini E; Sea Care team; Muratore A, Ferrara F, Lucentini L, Martuzzi M, Piccioli A. (2024) Tracing the footprints of SARS-CoV-2 in oceanic waters. The Science of Total Environment. 906:167343. https://doi.org/10.1016/j.scitotenv.2023.167343
Lavezzo E, et al.. (2020). Suppression of a SARS-CoV-2 outbreak in the Italian municipality of Vo'. Nature 584(7821):425-429. Epub 2020 Jun 30. Erratum in: Nature. 2021 Feb; 590(7844):E11. https://doi.org/10.1038/s41586-020-2956-7
Le Bert N, Tan AT, Kunasegaran K, Tham CYL, Hafezi M, Chia A, Chng MHY, Lin M, Tan N, Linster M, Chia WN, Chen MI, Wang LF, Ooi EE, Kalimuddin S, Tambyah PA, Low JG, Tan YJ, Bertoletti A. (2020). SARS-CoV-2-specific T cell immunity in cases of COVID-19 and SARS, and uninfected controls. Nature Aug 584(7821):457-462. https://doi.org/10.1038/s41586-020-2550-z
Leparc-Goffart I, Hingley ST, Chua MM, Jiang X, Lavi E, Weiss SR. (1997). Altered pathogenesis of a mutant of the murine coronavirus MHV-A59 is associated with a Q159L amino acid substitution in the spike protein. Virology. 239(1):1-10. doi: 10.1006/viro.1997.8877. https://www.sciencedirect.com/science/article/pii/S0042682297988772
Lundberg GD. (2018). Irreproducible “scientific” results, Medscape Mar 06, 2018. https://www.medscape.com/viewarticle/893097
Maddox J. (1988). Finding wood among the trees. Nature 355:11. https://doi.org/10.1038/333011a0
Mahallawi W, Ibrahim N. (2022). Unexpected Detection of Anti-SARS-CoV-2 Antibodies Before the Declaration of the COVID-19 Pandemic. Frontiers in Medicine (Lausanne). 9:923715. PMID: 35899210; PMCID: PMC9309723. https://doi.org/10.3389/fmed.2022.923715
Manning J, Zaidi I, Lon C, Rosas LA, Park JK, Ponce A, Bohl J, et al. (2022). SARS-CoV-2 Cross-Reactivity in Prepandemic Serum from Rural Malaria-Infected Persons, Cambodia. Emerging Infectious Diseases 28(2):440-444. https://doi.org/10.3201/eid2802.211725
Massey C. (2021). 225 health/science institutions worldwide all failed to cite even 1 record of “SARS-COV-2” purification, by anyone, anywhere, ever. June 6, 2021 (last update September 28, 2024). https://www.fluoridefreepeel.ca/68-health-science-institutions-globally-all-failed-to-cite-even-1-record-of-sars-cov-2-purification-by-anyone-anywhere-ever/
Menachery VD, Yount BL Jr, Debbink K, Agnihothram S, Gralinski LE, Plante JA, Graham RL, et al. (2015) A SARS-like cluster of circulating bat coronaviruses shows potential for human emergence. Nature Medicine 21, 1508-1513. https://doi.org/10.1038/nm.3985
Mullis et al. (1987). Process for amplifying, detecting, and/or-cloning nucleic acid sequences. United States Patent. patent number 4,683,195. https://patentimages.storage.googleapis.com/ec/14/bf/0a414f77b2d203/US4683195.pdf
Oller JW (2021). Weaponized pathogens and the SARS-CoV-2 pandemic. International Journal of Vaccine Theory, Practice, and Research, 1(2), 172-208. https://doi.org/10.56098/ijvtpr.v1i2.16
Pantazatos, S. P., & Seligman, H. (2025). COVID vaccination and age-stratified all-cause mortality risk. International Journal of Vaccine Theory, Practice, and Research, 4(1). https://doi.org/10.56098/rbvsmw07
Popper K (1934/1959). The Logic of Scientific Discovery. Julian Springer/Routledge. https://openlibrary.org/books/OL7489739M/
Rapley, B. (2025). From innovation to inquiry—COVID-19 mRNA vaccination and its global consequences—With special reference to New Zealand. International Journal of Vaccine Theory, Practice, and Research, 4(1), 1487–1516. https://doi.org/10.56098/hqjnk479
Reuters Health News. (2020). Thousands of Swedes got a false positive COVID-19 result due to a test kit fault (August 25, 2020). https://www.reuters.com/article/us-health-coronavirus-sweden-testing-idUSKBN25L1XF
Rubínová E & Price HL. (2024). Primacy (and recency) effects in delayed recognition of items from instances of repeated events. Memory, 32(5), 627–645. https://doi.org/10.1080/09658211.2024.2354764
Segalla G (2024). Adjuvant activity and toxicological risks of lipid nanoparticles contained in the COVID 19 "mRNA vaccines. International Journal of Vaccine Theory, Practice, and Research 3(2):1085-1102. https://doi.org/10.56098/z1ydjm29
Sencer, DJ (1981, 2024). The AIDS Epidemic in the United States, 1981-early 1990s. https://www.cdc.gov/museum/online/story-of-cdc/aids/index.html
Serpieri R & Franchi F (2024). Resilience of DNA chains to molecular fracture after PCR heating cycles and implications on PCR reliability, Quarterly Reviews of Biophysics, 57, p. e8. https://doi.org/10.1017/S0033583524000064
Sender R, Bar-On YM, Gleizer S, Bernshtein B, Flamholz A, Phillips R, Milo R. (2021). The total number and mass of SARS-CoV-2 virions. Proceedings of the National Academy of Sciences. U S A. 2021 Jun 22;118(25):e2024815118. https://doi.org/10.1073/pnas.2024815118
Watson J, Whiting PF, Brush JE (2020). Interpreting a COVID-19 test result. British Medical Journal 369:M1808. https://doi.org/10.1136/bmj.m1808
Wenstrup BR, Runz R (2024). Final Report. US House of Representatives. The Lessons Learned and a Path Forward. Select Subcommittee on the Coronavirus Pandemic. https://oversight.house.gov/release/final-report-covid-select-concludes-2-year-investigation-issues-500-page-final-report-on-lessons-learned-and-the-path-forward/
WHO (2020a). COVID-19 Case definition. updated in Public health surveillance for COVID-19. https://www.who.int/publications/i/item/WHO-2019-nCoV-Surveillance_Case_Definition-2020.1 (Now, it is not possible to retrieve it from the website, because the link leads to the updated definition of July 22, 2022, modified from that of 2020. The 2020 one can be found here: https://web.archive.org/web/20201010191309/https://apps.who.int/iris/rest/bitstreams/1296485/retrieve) (
WHO (2020b) Medical product alert. Information Notice for IVD Users. Nucleic acid testing (NAT) technologies that use real-time polymerase chain reaction (RT-PCR) for detection of SARS-CoV-2. (14 December 2020). https://web.archive.org/web/20201214195523/https://www.who.int/news/item/14-12-2020-who-information-notice-for-ivd-users
Wilson FP (2020). COVID 'Immunity Passport' No More Reliable Than a Coin Flip. https://www.medscape.com/viewarticle/931097
Woloshin S, Patel N, & Kesselheim AS (2020). False negative tests for SARS-CoV-2 infection-challenges and implications. The New England Journal of Medicine, 383 e38. https://doi.org/10.1056/NEJMp2015897
Wu F, Zhao S, Yu B, Chen YM, Wang W, Song ZG, Hu Y, Tao ZW, Tian JH, Pei YY, Yuan ML, Zhang YL, Dai FH, Liu Y, Wang QM, Zheng JJ, Xu L, Holmes EC, Zhang YZ. (2020). A new coronavirus associated with human respiratory disease in China. Nature 579, 265-269. https://doi.org/10.1038/s41586-020-2008-3
Yan L-M, Kang S, Guan J,Hu, S (2020). SARS-CoV-2 is an unrestricted bioweapon: a truth revealed through uncovering a large-scale, organized scientific fraud. https://www.winterwatch.net/2020/10/sars-cov-2-is-an-unrestricted-bioweapon-a-truth-revealed-through-uncovering-a-large-scale-organized-scientific-fraud/
Zhou P, et al. (2020). A pneumonia outbreak associated with a new coronavirus of probable bat origin. Nature 579, 270-273 (2020). https://doi.org/10.1038/s41586-020-2012-7
Downloads
Published
Issue
Section
License
Copyright (c) 2025 Fabio Franchi

This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
The copyright for materials in this journal, IJVTPR, is owned by the author. The author, however, grants first right of publication to the journal, IJVTPR and assures the editorial staff of the journal that the work submitted has not simultaneously been submitted to any other journal, nor is it under consideration for publication by any other journal. If any portion of the work submitted has appeared elsewhere, the quoted material is properly cited and credit is given to the original publisher. The submitting author (or the principal and corresponding author of the work) also assures the editors of IJVTPR that he or she has obtained all required written permissions from any quoted authors or publishers of quoted materials. The submitting author also agrees to hold IJVTPR and its editorial staff harmless from any infractions of copyright law that may be discovered at any time in the future in the submitted work. The author assures the editorial staff at IJVTPR that none of the work submitted is plagiarized, and that any recycled or precycled material by the author is identified as such with proper credits in the text to any other parties holding a copyright interest in the quoted material.